Advertisement
UK markets close in 3 hours 32 minutes
  • FTSE 100

    8,092.81
    +52.43 (+0.65%)
     
  • FTSE 250

    19,714.89
    -4.48 (-0.02%)
     
  • AIM

    755.21
    +0.52 (+0.07%)
     
  • GBP/EUR

    1.1671
    +0.0026 (+0.23%)
     
  • GBP/USD

    1.2510
    +0.0048 (+0.39%)
     
  • Bitcoin GBP

    51,034.27
    -2,151.98 (-4.05%)
     
  • CMC Crypto 200

    1,358.14
    -24.43 (-1.77%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD FUTURES

    2,341.90
    +3.50 (+0.15%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,966.55
    -122.15 (-0.68%)
     
  • CAC 40

    8,013.24
    -78.62 (-0.97%)
     

Wasatch Invests in 7 New Holdings

- By David Goodloe

Wasatch International Growth (Trades, Portfolio) invested in seven new holdings in the third quarter. All but one are new to the portfolio; the exception had a brief presence in the fund's portfolio in the last five years. Wasatch is the only guru shareholder of all seven companies.


The fund bought 1,232,774 shares of Nien Made Enterprise Co. Ltd. (8464.TW), a Taiwan-based company that makes and sells window treatments, primarily curtains, blinds and shutters, for an average price of 341.93 Taiwan dollars ($10.61) per share. The transaction had a 1.11% impact on the portfolio.

Nien Made Enterprise has a price-earnings (P/E) ratio of 28.62, a price-book (P/B) ratio of 9.57 and a price-sales (P/S) ratio of 5.25. GuruFocus gives Nien Made Enterprise a Financial Strength rating of 8/10 with no debt and a Profitability and Growth rating of 6/10 with return on equity (ROE) of 35.97% that is higher than 95% of the companies in the Global Home Furnishings & Fixtures industry and return on assets (ROA) of 21.71% that is higher than 96% of the companies in that industry.

1481580930897.png
1481580930897.png



Nien Made Enterprise sold for 346 Taiwan dollars per share last week. The DCF Calculator gives Nien Made Enterprise a fair value of 128.85 Taiwan dollars.

The fund invested in 1,122,013 shares of XXL ASA (XXL.OL), a Norway-based sporting goods retailer, for an average price of 102.33 Norwegian kroner ($12.01) per share. The deal had a 1.08% impact on the portfolio.

XXL has a P/E ratio of 34.28, a P/B ratio of 4.20 and a P/S ratio of 1.91. GuruFocus gives XXL a Financial Strength rating of 5/10 and a Profitability and Growth rating of 5/10 with ROE of 12.49% that is higher than 72% of the companies in the Global Specialty Retail industry and ROA of 7.05% that is higher than 76% of the companies in that industry.

1481580888888.png
1481580888888.png



XXL sold for 102.5 Norwegian kroner. The DCF Calculator gives XXL a fair value of 32 Norwegian kroner.

The fund purchased 1,128,169 shares of UPL Ltd. (UPL.NS), an India-based crop protection, chemicals and seeds company, for an average price of 621.75 Indian rupees ($9.21) per share. The transaction had a 0.8% impact on the portfolio.

UPL has a P/E ratio of 22.84, a P/B ratio of 4.07 and a P/S ratio of 2.08. GuruFocus gives UPL a Financial Strength rating of 5/10 and a Profitability and Growth rating of 6/10 with ROE of 49.60% that is higher than 94% of the companies in the Global Agricultural Inputs industry and ROA of 19.39% that is higher than 92% of the companies in that industry.

1481580845298.png
1481580845298.png



UPL sold for 700.15 rupees per share. The DCF Calculator gives UPL a fair value of 823.89 rupees with a 15% margin of safety.

The fund bought 1,092,438 shares of Clinigen Group PLC (CLIN.L), a U.K.-based pharmaceutical company, for an average price of 6.5 British pounds ($8.17) per share. The deal had a 0.71% impact on the portfolio.

Wasatch sold its previous stake in Clinigen in the first quarter of 2015.

Clinigen has a P/E ratio of 59.78, a forward P/E ratio of 17.42, a P/B ratio of 3.48 and a P/S ratio of 2.41. GuruFocus gives Clinigen a Financial Strength rating of 6/10 and a Profitability and Growth rating of 7/10 with ROE of 6.09% that is lower than 72% of the companies in the Global Medical Distribution industry and ROA of 3.04% that is lower than 58% of the companies in that industry.

8a47c69a9205dba01e502a6f40582faa.png
8a47c69a9205dba01e502a6f40582faa.png



Clinigen Group sold for 7.21 British pounds. The DCF Calculator gives Clinigen a fair value of 1.18 British pounds.

The fund invested in 20,083 shares of Hugel Inc. (XKRX:145020), a South Korean pharmaceutical company, for an average price of 394,864 South Korean won ($334.81) per share. The transaction had a 0.54% impact on the portfolio.

Hugel has a P/E ratio of 49.52, a P/B ratio of 6.53 and a P/S ratio of 23.99. GuruFocus gives Hugel a Financial Strength rating of 9/10 and a Profitability and Growth rating of 5/10 with ROE of 15.54% that is higher than 76% of the companies in the Global Drug Manufacturers - Specialty & Generic industry and ROA of 14.80% that is higher than 89% of the companies in that industry.

1481580710624.png
1481580710624.png



Hugel sold for 324,200 won. The DCF Calculator gives Hugel a fair value of 72,781.81.

The fund purchased 205,579 shares of Japan Material Co. Ltd. (TSE:6055), a Japanese manufacturer of specialty gas supply devices, for an average price of 3,632.5 Japanese yen ($31.49) per share. The deal had a 0.54% impact on the portfolio.

Japan Material has a P/E ratio of 18.93, a P/B ratio of 4.06 and a P/S ratio of 2.68. GuruFocus gives Japan Material a Financial Strength rating of 7/10 and a Profitability and Growth rating of 6/10 with ROE of 22.60 that is higher than 86% of the companies in the Global Software - Application industry and ROA of 14.94% that is higher than 89% of the companies in that industry.

1481580661944.png
1481580661944.png



Japan Material sold for 3,425 yen per share. The DCF Calculator gives Japan Material a fair value of 1,859.73 yen.

The fund bought 1,568,363 shares of Trade Me Group Ltd. (TME.NZ), a New Zealand-based Internet auction website, for an average price of 5.27 New Zealand dollars ($3.76) per share. The transaction had a 0.45% impact on the portfolio.

Trade Me Group has a P/E ratio of 25.88, a forward P/E ratio of 21.88, a P/B ratio of 2.78 and a P/S ratio of 8.88. GuruFocus gives Trade Me Group a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10 with ROE of 11.17% that is higher than 65% of the companies in the Global Internet Content & Information industry and ROA of 8.84% that is higher than 73% of the companies in that industry.

1481580622241.png
1481580622241.png



Trade Me Group sold for 4.87 New Zealand dollars per share. The DCF Calculator gives Trade Me Group a fair value of 2.02 New Zealand dollars.

Disclosure: I do not own any stocks mentioned in this article.

Start afree seven-day trialof Premium Membership to GuruFocus.
This article first appeared on GuruFocus.